Ney D M, Yang H, Smith S M, Unterman T G
Department of Nutritional Sciences, University of Wisconsin-Madison 53706.
Metabolism. 1995 Feb;44(2):152-60. doi: 10.1016/0026-0495(95)90258-9.
High-calorie total parenteral nutrition (TPN) is associated with hepatic dysfunction and steatosis. Because TPN-induced steatosis might compromise hepatic expression of insulin-like growth factor-I (IGF-I) and thereby limit its potential nutritional benefit, we examined hormonal and IGF-I responses in male Sprague-Dawley rats (270 to 300 g) fed by continuous intravenous infusion with high-calorie, high-dextrose (350 kcal/kg) TPN solutions for O (control), 2, 4, and 8 days. Since IGF-binding proteins (IGFBPs) are thought to modulate the biological effects of IGFs in target tissues, we also determined serum levels of IGFBPs. Animals developed hepatic steatosis after 2 to 8 days of TPN, as reflected by a sevenfold to 15-fold increase in hepatic triacylglycerol content (P < .001 v control on each day). Serum corticosterone and insulin levels were significantly higher after 2 and 4 days of TPN, whereas serum growth hormone levels were reduced after 4 and 8 days. Serum IGF-I levels were not significantly different during TPN. However, there was a coordinate reduction in the three major hepatic IGF-I transcripts (7.0, 1.9, and 1.0 kb) after 2, 4, or 8 days of TPN, and IGF-I transcripts corresponding to multiple initiation sites within exons 1 and 2 were coordinately downregulated with TPN. Western ligand blotting indicated that serum levels of 38K to 43K, 30K to 34K, and 24K IGFBPs were increased approximately twofold after 4 and 8 days of TPN as compared with control values.(ABSTRACT TRUNCATED AT 250 WORDS)
高热量全胃肠外营养(TPN)与肝功能障碍和脂肪变性有关。由于TPN诱导的脂肪变性可能会损害肝脏中胰岛素样生长因子-I(IGF-I)的表达,从而限制其潜在的营养益处,我们研究了雄性Sprague-Dawley大鼠(270至300克)通过连续静脉输注高热量、高葡萄糖(350千卡/千克)TPN溶液0天(对照)、2天、4天和8天后的激素和IGF-I反应。由于胰岛素样生长因子结合蛋白(IGFBPs)被认为可调节IGFs在靶组织中的生物学效应,我们还测定了血清IGFBPs水平。TPN治疗2至8天后,动物出现肝脏脂肪变性,肝脏三酰甘油含量增加7至15倍(与每天的对照组相比,P <.001)。TPN治疗2天和4天后,血清皮质酮和胰岛素水平显著升高,而4天和8天后血清生长激素水平降低。TPN期间血清IGF-I水平无显著差异。然而,TPN治疗2天、4天或8天后,肝脏中三种主要的IGF-I转录本(7.0、1.9和1.0 kb)协同减少,外显子1和2内多个起始位点对应的IGF-I转录本随TPN协同下调。Western配体印迹表明,与对照值相比,TPN治疗4天和8天后,38K至43K、30K至34K和24K IGFBPs的血清水平增加了约两倍。(摘要截断于250字)